We have previously shown that tumor-infiltrating T cells expressing a TCR against a tumor-specific neoepitope in a vaccinated patient with glioma could be distinguished from bystander T cells on the basis of their expression of CXCL13 and CD40LG15. Here, CXCL13 is linked to neoplasm.